These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6922790

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 23. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA, Hutchins GM.
    Am J Perinatol; 1998 Jul; 15(9):539-44. PubMed ID: 9890252
    [Abstract] [Full Text] [Related]

  • 24. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ, Chen C, Jin QL, Shao XM.
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [Abstract] [Full Text] [Related]

  • 25. Combined effects of high-frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome.
    Calkovska A, Sun B, Curstedt T, Renheim G, Robertson B.
    Acta Anaesthesiol Scand; 1999 Feb; 43(2):135-45. PubMed ID: 10027019
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
    Sánchez-Mendiola M, Martínez-Natera OC, Herrera-Maldonado N, Ortega-Arroyo J.
    Gac Med Mex; 2005 Feb; 141(4):267-71. PubMed ID: 16164120
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention.
    Goldsmith LS, Greenspan JS, Rubenstein SD, Wolfson MR, Shaffer TH.
    J Pediatr; 1991 Sep; 119(3):424-8. PubMed ID: 1880658
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
    Robertson B, Curstedt T, Grossmann G, Kobayashi T, Kokubo M, Suzuki Y.
    Eur J Pediatr; 1988 Feb; 147(2):168-73. PubMed ID: 3366134
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O, Lapillonne A, Madinier-Chappat N, Miguet D, Salle BL.
    Cah Anesthesiol; 1994 Feb; 42(3):325-8. PubMed ID: 7812856
    [Abstract] [Full Text] [Related]

  • 40. Surfactant replacement therapy.
    Kresch MJ, Lin WH, Thrall RS.
    Thorax; 1996 Nov; 51(11):1137-54. PubMed ID: 8958900
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.